To overcome these limitations, the team used cyclodextrins, a family of natural oligosaccharides produced from starch, to create an inclusion compound, binding the lawsone molecules within the ...

An study led by researchers from the Harbin Institute of Technology has unveiled a substantial development in wastewater ...

This strategy allowed them to create a combination that efficiently bound the lawsone molecules within the cyclodextrin framework. Using electrospinning equipment, the researchers formed a homogeneous ...

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company’s lead ...

Sugammadex, a modified γ-cyclodextrin, is the first selective relaxant binding agent. Sugammadex forms very tight complexes in a 1:1 ratio with steroidal neuromuscular blocking agents (rocuronium ...

Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent GlioblastomaCohort A Data ...

Aqneursa has been approved to treat neurological symptoms associated with NPC in children and adults who weigh at least 15kg, ...

A team at Tsinghua University led by Jiang-Fei Xu and Xi Zhang have published a paper detailing their radical new approach to ...

Some of the polymer molecules were functionalized with the specific chemical, β-cyclodextrin (βCD), and others with adamantane (Ad) residues. However, the microparticles did not assemble until a ...

Rotaxanes have garnered interest for their unique structures consisting of mechanically interlocked axles and macrocycles. Numerous organic macrocycles have been employed to construct rotaxanes ...

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick ...